首页> Molecules (Basel, Switzerland)> A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin.

A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin.

导出 OA

翻译打印收藏纠错

第一作者： Jinghong,Xian

第一单位： Department of Clinical Research Management, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, West China Hospital, Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu 610041, China.

作者： Jinghong,Xian ^[1] ; Faqian,Bu ^[2] ; Yuxi,Wang ^[3] ; Fangyi,Long ^[4] ; Zhixiong,Zhang ^[3] ; Chengyong,Wu ^[2] ; Yiran,Tao ^[3] ; Ting,Wang ^[4] ; Guan,Wang ^[2]

作者单位： Department of Clinical Research Management, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, West China Hospital, Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu 610041, China. ^[1] Department of Clinical Research Management, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, West China Hospital, Collaborative Innovation Center of Biotherapy, Sichuan University, Chengdu 610041, China.;Precision Medicine Research Center, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. ^[2] Precision Medicine Research Center, Department of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. ^[3] Department of Pharmacy, Sichuan Cancer Hospital & Institution, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China. ^[4]

关键词 IC261 colchicine binding site crystal structure drug design tubulin